# Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease

> **NCT00982072** · PHASE4 · COMPLETED · sponsor: **Imperial College Healthcare NHS Trust** · enrollment: 52 (actual)

## Conditions studied

- Minimal Change Disease

## Interventions

- **DRUG:** tacrolimus
- **DRUG:** prednisolone

## Key facts

- **NCT ID:** NCT00982072
- **Lead sponsor:** Imperial College Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2019-10-10
- **Final completion:** 2019-10-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2021-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00982072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00982072, "Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00982072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*